Syncom Details

Syncom

Company Profile:

Syncom provides intellectual and practical chemistry services for the construction of small molecules.  Syncom is a privately owned company established in 1988.  It has grown rapidly in recent years and currently employs 130 chemists 75 of whom have PhD degrees and the rest a masters degree or equivalent.  About 95% of the work carried out is for the pharmaceutical industry and the other 5% is devoted to the synthesis of organic molecules for other purposes.  The company is involved in synthetic support for medicinal chemistry, drug discovery and chemical development.  Syncom is located in the Groningen in The Netherlands.  We have a good track record with big and medium sized pharma and biotech companies from both Europe and the US.

Previous Clients:
We have major FTE collaborations which support discovery groups in big pharma and biotech. Within these collaborations we work on a variety of projects. We operate as an extension of the R&D groups from our clients

Key Products:

• Drug Discovery Services.  Hit and lead optimization, libraries based upon original scaffolds and building blocks, reference compounds, synthesis support
• Development and scale up.  Route scouting, GLP synthesis for tox studies, metabolites, impurities, scale up, intermediates
• Chirality, first-time-right concept.  Integral approach: simultaneous screening of resolution, chemo- and biocatalysis and chiral pool

Website:
www.syncom.nl